Device-related Mycobacterium mageritense Infection in a Patient Treated with Nivolumab for Metastatic Breast Cancer

Treatment with anti-programmed cell death-1 (PD-1) antibodies improves the anti-cancer immune response and can provide a meaningful clinical benefit to cancer patients. However, this treatment can result in specific autoimmune toxicities, termed immune-related adverse events (irAEs). Although irAEs...

Descripción completa

Detalles Bibliográficos
Autores principales: Koyama, Taiji, Funakoshi, Yohei, Imamura, Yoshinori, Nishimura, Sho, Fujishima, Yoshimi, Toyoda, Masanori, Kiyota, Naomi, Tanino, Hirokazu, Minami, Hironobu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627816/
https://www.ncbi.nlm.nih.gov/pubmed/33994435
http://dx.doi.org/10.2169/internalmedicine.6550-20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627816/
https://www.ncbi.nlm.nih.gov/pubmed/33994435
http://dx.doi.org/10.2169/internalmedicine.6550-20

Ejemplares similares